propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.propranolol has recently been introduced as a novel pharmacologic treatment for infantile hemangiomas. systematic examination of this treatment in a tertiary care setting has not been described. this study explores the impact of propranolol on both proliferative and involuting hemangiomas at a tertiary vascular anomalies center.201020112413
parental emotional and time costs predict compliance with respiratory syncytial virus prophylaxis.two agents are effective in preventing respiratory syncytial virus (rsv) hospitalization in premature infants: rsv immune globulin (rsv-ig) and palivizumab. rsv-ig is associated with greater parental emotional and time costs, which may account for the more limited adherence to recommended monthly treatment with this agent.200212437390
Displaying items 1 - 2 of 2